Medical Conditions and Guidelines Flashcards

A CMV driver presents with a blood pressure reading of 166/96 mmHg. He has no history of cardiovascular disease and is not taking any antihypertensive medications. What is the appropriate certification action under FMCSA advisory criteria?

Answer: Issue a one-time certificate not to exceed 3 months and recommend treatment; certify for 1 year at follow-up if controlled

A systolic reading of 166 mmHg places this driver in the Stage 2 hypertension range (160–179 mmHg systolic), regardless of the diastolic reading being in the Stage 1 range. Under FMCSA advisory criteria, when systolic and diastolic values fall in different stages, the higher stage governs. Stage 2 hypertension warrants a one-time certificate not to exceed 3 months to allow for treatment initiation and follow-up. If blood pressure is reduced to Stage 1 or below at the follow-up visit, a standard 1-year certificate may be issued.

A driver enrolled in the FMCSA Insulin-Treated Diabetes Mellitus (ITDM) Exemption Program checks his blood glucose 50 minutes before starting a long-haul route and records a reading of 78 mg/dL. His last meal was approximately 2 hours ago. What is the correct course of action?

Answer: Consume a carbohydrate snack, wait for the glucose to stabilize, recheck, and only drive once blood glucose is confirmed ≥ 80 mg/dL

Under FMCSA ITDM Exemption Program requirements, a driver must not operate a CMV if pre-drive blood glucose is below 80 mg/dL. A reading of 78 mg/dL falls below this threshold, making it unsafe and non-compliant to drive regardless of timing. The correct response is to consume carbohydrates, allow sufficient time for absorption, recheck, and confirm blood glucose is at or above 80 mg/dL before driving. Operating below threshold carries a significant risk of hypoglycemia-induced impairment.

A 54-year-old CDL driver had a myocardial infarction and subsequent coronary artery bypass grafting (CABG) 5 months ago. He is now asymptomatic and reports good daily activity tolerance. His cardiologist documents an ejection fraction of 44% and a nuclear stress test where the driver achieved 5.2 METs without electrocardiographic evidence of ischemia or arrhythmia. What is the most appropriate certification decision?

Answer: Do not certify — the driver did not achieve the minimum exercise capacity of ≥ 6 METs required by FMCSA advisory criteria for post-cardiac event clearance

FMCSA cardiovascular advisory criteria for drivers following a myocardial infarction or cardiac surgery require demonstrated adequate functional capacity — typically defined as achieving ≥ 6 METs on exercise stress testing without significant ischemia, serious arrhythmia, or other adverse findings. This driver achieved only 5.2 METs, falling below the required threshold. A mildly reduced ejection fraction of 44% is not itself an absolute disqualifier, but the failure to reach ≥ 6 METs is the determinative finding here. Certification should be deferred until functional capacity is reassessed and meets the benchmark.

A 47-year-old driver reports new-onset intermittent horizontal double vision over the past 6 weeks. On examination, binocular diplopia is reproducible in lateral gaze but not in primary (forward) gaze. His corrected visual acuity is 20/25 bilaterally and peripheral fields are full. What is the most appropriate action for the certified medical examiner?

Answer: Do not certify — disqualify until the etiology of the diplopia is established and a specialist confirms no diplopia exists within the driver's functional visual field

Binocular diplopia is disqualifying under FMCSA vision standards. Even if diplopia is only elicited in lateral gaze during the exam, new-onset diplopia may represent a serious and progressive underlying condition — cranial nerve palsy, myasthenia gravis, an intracranial mass, or demyelinating disease — that could involve primary gaze over time. The medical examiner must not certify until the cause is identified and a specialist confirms no diplopia is present in the functional visual field relevant to driving. Recommending a monocular patch is not an acceptable workaround and does not address the underlying pathology or meet the federal standard.

A 38-year-old driver discloses that 2 years ago he experienced a single tonic-clonic seizure during sleep. Subsequent MRI, EEG, and full neurological evaluation revealed no structural lesion, no epileptiform abnormality, and no identifiable etiology. No anticonvulsant medication was prescribed and no formal diagnosis of epilepsy was made. He has had no further episodes. Which statement most accurately describes his certifiability under FMCSA standards?

Answer: He may be certifiable following individualized neurological evaluation; the regulation targets conditions likely to cause recurrent loss of consciousness, and a single, non-recurring seizure without an epilepsy diagnosis requires individualized risk assessment

49 CFR 391.41(b)(8) disqualifies drivers with 'epilepsy or any other condition which is likely to cause loss of consciousness.' The operative concept is a condition predisposing to recurrent events. FMCSA advisory criteria recognize an important distinction: a single isolated seizure event, thoroughly evaluated with no identified epileptogenic substrate and no formal epilepsy diagnosis, is not equivalent to a confirmed diagnosis of epilepsy. Such a case requires individualized neurological assessment to quantify the risk of recurrence. If the risk is deemed acceptably low, certification may be possible. Automatic permanent disqualification is not mandated in the absence of an epilepsy diagnosis.

A 41-year-old CDL holder discloses a 3-year history of bipolar disorder type I, well-controlled on lithium carbonate 900 mg/day and aripiprazole for 26 months with no hospitalizations, manic episodes, or depressive episodes during that time. His psychiatrist provides written clearance documenting no functional impairment and adequate illness insight. His lithium serum level is 0.9 mEq/L (within therapeutic range). Which of the following represents the most defensible certification approach?

Answer: Certify for 1 year — documented stability exceeding 2 years, specialist clearance, no functional impairment, and therapeutic medication levels support annual certification

Bipolar disorder type I is not categorically disqualifying under FMCSA regulations. The evaluation centers on functional impairment and the likelihood of sudden incapacitation. With 26 months of documented psychiatric stability, no hospitalizations or acute episodes, written specialist clearance, therapeutic lithium levels, and no functional impairment, this driver meets the criteria for certification. A 1-year certificate with ongoing psychiatric monitoring is appropriate and defensible. FMCSA does not mandate quarterly recertification for psychiatric conditions absent documented instability. The medical examiner should retain the specialist's written clearance in the driver's file.